Huntington Ingalls Industries (HII)
NYSEIndustrialsAerospace & DefenseSnapshot 2026-07-08
$289.28-0.06%
Close 2026-07-08 · 1-day change
Reading HII? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track HII free→NYSEIndustrialsAerospace & DefenseSnapshot 2026-07-08
Reading HII? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track HII free→A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a durable compounder with a focus on defense and shipbuilding. The current thesis state is intact, supported by strong recent financial performance, but it faces challenges in meeting ambitious management targets.
The valuation is considered cheap compared to peers, with a notable expectations gap. The market appears to have priced in a stable outlook, but there is a risk of downward adjustments if guidance is cut.
Fundamentals are likely to show mixed results in the near term. Management aims to increase shipbuilding throughput and achieve specific revenue targets, but recent performance indicates challenges, particularly in free cash flow.
The thesis hinges on the performance of sector bellwethers like SPCX, GE, and RTX. If these companies continue to perform well, it could support HII's momentum; however, any misses could negatively impact the entire sector.
Over the next 1 to 3 years, HII's performance will depend on its ability to meet management goals and the broader industrial sector's health. Not investment advice.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports the positive view. Winning defense awards and contracts boosts shipbuilding throughput by about 15% in 2026. There are no current threats to the thesis.
as of 2026-07-08
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: A growing backlog shows strong demand. It also means more money for HII later.
Confirms:Total backlog was over $55 billion after Q2 2026.
Disproves:Total backlog falls below $54 billion after Q2 2026.
Why it matters: This revenue target is part of HII's goal for FY26. It shows progress in a key growth area.
Confirms:Mission Technologies made $750 million or more in revenue in Q2.
Disproves:Mission Technologies revenue in Q2 falls below $700 million.
Why it matters: Steady earnings growth shows good performance and strong demand in the market.
Confirms:Q2 2026 diluted earnings per share matches or exceeds $4.04.
Disproves:Q2 2026 diluted earnings per share drops below $3.50.
Why it matters: Strong free cash flow supports HII's financial health and ability to invest in growth.
Confirms:Free cash flow reported between $125 million and $150 million for Q2 2026.
Disproves:Free cash flow is negative or below $100 million in Q2 2026.
Why it matters: HII's technology is in high demand. Meeting this target shows that.
Confirms:FY26 Mission Technologies revenue reported within the range of $3.0B to $3.2B.
Disproves:Mission Technologies made less than $3.0B in revenue.
Why it matters: Free cash flow helps pay for operations and growth. Better cash flow shows good management.
Confirms:Free cash flow for FY26 reaches $500 million or more.
Disproves:Free cash flow remains negative or below $400 million for FY26.
Why it matters: A 15% increase in shipbuilding throughput is key for HII's growth plans. This shows how well the company is managing production and meeting demand.
Confirms:Shipbuilding throughput growth reaches or exceeds 15% in 2026.
Disproves:Throughput growth falls below 10% in 2026.
Why it matters: New contracts are vital for revenue growth and backlog. High awards indicate strong demand for HII's services.
Confirms:New contract awards in Q2 exceed $2 billion.
Disproves:New contract awards in Q2 fall below $1 billion.